Ellenbecker Investment Group Bristol Myers Squibb CO Transaction History

Ellenbecker Investment Group

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $1,210 - $1,344	19 Added 0.5%	3,843 $245,000
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $1,117 - $1,267	17 Added 0.45%	3,824 $265,000
Q4 2022 Jan 11, 2023	BUY	$68.48 - $81.09 $1,095 - $1,297	16 Added 0.42%	3,807 $273,000
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $2 - $1,229	16 Added 0.42%	3,791 $269,000
Q2 2022 Jul 05, 2022	BUY	$72.62 - $79.98 $1,161 - $1,279	16 Added 0.43%	3,775 $290,000
Q1 2022 Apr 13, 2022	BUY	$61.48 - $73.72 $1,106 - $1,326	18 Added 0.48%	3,759 $274,000
Q4 2021 Jan 04, 2022	SELL	$53.63 - $62.52 $7,829 - $9,127	-146 Reduced 3.76%	3,741 $233,000
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $2,425 - $2,841	-41 Reduced 1.04%	3,887 $230,000
Q2 2021 Jul 07, 2021	BUY	$61.91 - $67.42 $4,147 - $4,517	67 Added 1.74%	3,928 $262,000
Q1 2021 Apr 06, 2021	SELL	$59.34 - $66.74 $2,254 - $2,536	-38 Reduced 0.97%	3,861 $244,000
Q4 2020 Jan 13, 2021	BUY	$57.74 - $65.43 $225,128 - $255,111	3,899 New	3,899 $242,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ellenbecker Investment Group, based on Form 13F filings with the SEC.

Stay updated on Ellenbecker Investment Group with notifications on news.